Loading stock data…
HIT
$1.55+0.10 (+6.90%)
Market ClosedLast close May 1
Health In Tech, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Health In Tech, Inc. in the Technology sector is trading at $1.55. The stock is currently 61% below its 52-week high of $4.02, remaining 23.3% below its 200-day moving average. Technical signals show neutral RSI of 61 and bullish MACD crossover, explaining why HIT maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 61) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
AAPLMSFTGOOGL
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.55
Potential Downside
76.4%
Whystock Fair Value$0.37
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Health In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$108.17M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
82.50
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
7.47%
Volume
Today's trading volume
54,939
Recent News
Health In Tech HIT Q2 2025 Earnings Transcript
Joining us today are Mr. Tim Johnson, Chief Executive Officer, Mr. Dustin Plantholt, Chief Growth Officer, and Ms. Julia Chen, Chief Financial Officer. With that, I now turn the call over to our CEO, Mr. Tim Johnson.
Is Now The Time To Put Health In Tech (NASDAQ:HIT) On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Health In Tech, Inc. Q4 2025 Earnings Call Summary
Moby summary of Health In Tech, Inc.'s Q4 2025 earnings call
Health In Tech Q4 Earnings Call Highlights
Health In Tech (NASDAQ:HIT) executives used the company’s fourth-quarter and full-year 2025 earnings call to highlight rapid top-line growth, continued distribution expansion, and product initiatives aimed at moving further upmarket in self-funded employer health insurance. 2025 described as a “piv
Traders Eye Fed Rate Decision as US Equity Futures Waver Pre-Bell
US equity futures were flat before Wednesday's opening bell as traders looked ahead to the Federal R